We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Haydale Graphene Industries Plc | LSE:HAYD | London | Ordinary Share | GB00BKWQ1135 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 1.10% | 0.46 | 0.45 | 0.47 | 0.46 | 0.455 | 0.46 | 2,935,788 | 08:36:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Indl Inorganic Chemicals,nec | 4.3M | -6.17M | -0.0034 | -1.35 | 8.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/1/2015 09:44 | Nicely cleared the £1 marker today, with the bid/ask on a narrow spread at 102p v 103p respectively. Still only 6mm's x 1k lots (total 6000shrs), with the highest of those on the bid now 112p. A tight market here. f | fillipe | |
29/1/2015 20:16 | A late 10,000 buy may mean opening above 100p | petewy | |
29/1/2015 13:41 | I thought it would pause for breath at around 92p as that was the price for the pre-IPO fund raise, but it seems I was mistaken. I'm now in profit overall even if I disregard the EIS tax breaks. That has to be worth another rampstastic animated Gif! | timbo003 | |
29/1/2015 12:09 | GUSC - another riser on small! Worth checking out. f | fillipe | |
29/1/2015 12:06 | A small handful of buys have taken out the 97p ask - now raised to 99p and the highest ask up at 105p. Level 2 totals showing only 6k each side bid/ask. I can see the 100p marker being crossed ere long. All this rise on a modest number of relatively small buys! f | fillipe | |
29/1/2015 09:24 | petewy -Thanks for the int's news. HAYD marked higher again, today....97p at the ask and then up to 103p, in more or less six 1p increments on a mere 1000shrs from each of six mm's. When at some stage there is hot news and the demand becomes strong for large trades, then HAYD will see a hefty spike. f | fillipe | |
27/1/2015 09:17 | From Trevor Phillips, Financial Public Relations to Haydale: "The date for the interim results has not yet been announced but is anticipated to be the second half of March." | petewy | |
26/1/2015 13:46 | I have watched all Graphene products and Hayd shares went straight down after being launched on AIM. The only news for the last two months which could cause this resurgence is the two new reactors. "Commissioning has already begun and we expect these reactors to be fully operational in January 2015" The other company is Graphene Industries Limited 2 Tupelo Street which is a university spin-off. I have bought in (Cantor Fitz noted) but is there something going on we don't know about? | petewy | |
24/1/2015 14:51 | Only 11.446m shrs in total at HAYD., so a hugely tight market when demand increases further. 19-12-14 Cantor Fitz reiterated BUY and 150p tp. I think int's are due about 23-2-15 f | fillipe | |
23/1/2015 10:43 | Not sure what's driving this one up, volumes traded seem to be minimal yet the share price has doubled since the December low. I am now actually making a small paper profit if I take into account the up front tax relief Average purchase price without tax relief: 92.8p/share Average purchase price with EIS tax relief: 71.8p/share I'm hangin' on in there. | timbo003 | |
22/12/2014 08:54 | A rather good appetite for HAYD shares.....and continuing today. Plenty to go for here - shares are still barely 25% of the April high. f | fillipe | |
19/12/2014 13:55 | The grant news this morning was a pleasant surprise. Probably a bit early for a few animated gifs of rockets taking off, but hey ho, why not? | timbo003 | |
17/12/2014 22:58 | There seems to have been quite a bit of director buying over the last few days, 22K, 23K and 24K, but without a huge impact on the price, I guess there must still be a bit of an overhang. I'm feeling a little bit smug as I managed to get in at a lower price than any of them (so far), but alas I suspect my average is somewhat higher than theirs, given that I have some IPO shares at 210p ! | timbo003 | |
15/12/2014 10:17 | 37p/share corresponds to a market cap of around £4M. With around £5M in the bank that's too cheap, so I bought a few (more). | timbo003 | |
04/12/2014 23:56 | The Haydale AGM was held on Wednesday December 3rd at the Offices of the Company’s Solicitors: Field Fisher Waterhouse, 2 Swan Lane, London EC4R 3TT. There were around 20 attendees which included the BOD, around 6 shareholders and a number of AGM functionaries. The Chairman John Knowles kicked off the meeting with a welcome and introductions, this was followed by shareholder questions and then the voting on the resolutions. There were only a few shareholder questions (mostly mine) asked in the formal part of the meeting and I asked several more after the meeting had officially finished. Ray Gibbs (CEO) fielded most of the questions. My main questions concerned the current IP situation and how this might affect the Haydale’s prospects, in particular progress (and possible third part infringments) for Haydale’s two patent applications concerning their current graphene technologies and “know-how&rdqu WO2010142953 WO2012076853 I also enquired about other third party patent applications which could potentially restrict Haydale’s freedom to operate. I do not think it is appropriate to go into detail of what was discussed regarding the IP on this public bulletin board, suffice to say that the EPO have so far looked favourably on the Haydale European patent applications. The Haydale BOD appear to be very alert to identifying and protecting any IP which might arise from their development activities. Furthermore they have regular meetings with the company’s patent attorneys (Mewburn Ellis LLP) and IP issues are discussed at every BOD meeting. My concerns regarding Ian Walters and Perpetuus have abated somewhat, based on what was discussed. The Perpetuus web site certainly appears very showy: ...but is it a case of all mouth and no action or deliverables? Has anyone connected with the industry or anyone connected to academic groups working with graphene actually seen any of their product? I don’t know the answer to those questions, but I guess time will tell. As previously pointed out earlier in this thread, The BOD confirmed that Perpetuus do indeed have 5 priority patent applications in the pipeline: The first of which publishes in May 2015 and it remains to be seen exactly what these applications disclose. The BOD seemed more concerned with what other third party Graphene specialists had been up to than with the Perpetuus activities. One company singled out for a mention was Vorbeck, apparently they might have claims on some broad IP concerning one particular graphene application (printing inks?). However, it sounded like Vorbeck’s IP might have more potential to restrict Haydale’s potential customers, rather than Haydale themselves. I asked about future fund raising, the response was that none was envisaged unless an unexpected opportunity came along such as a compelling acquisition. The directors seems perplexed by the low share price and market cap (not far off money in the bank), I opined that some sustained director buying might go some way to fixing that and said that I was tempted to buy some more at these levels, but thought they would go lower before they went higher with a nadir probably at the end of the tax year (due to usual small cap investor end of tax year dynamics, i.e. stale bulls balancing losses on losers with gains on winners to use up CGT allowance). No one seemed to disagree. I asked whether any action was being taken against the previous broker Hume for the chaotic after market following the IPO. The BOD stated that they were reasonably pleased with the money raised and the fall in the share price was due to IW selling off his stake. As far as the BOD were concerned the matter (with Hume) was now closed, although I sensed that some others (shareholders?) may wish to take things further on that issue. Before the meeting finally closed, I had a chance to talk individually to the Technical Director (CS), one of the NEDs (RS), the company broker (PJ) and one other shareholder (CB) all of whom gave me various helpful insights into the company’s history and prospects. It was particularly useful to hear the rationale behind the EPL acquisition, which initially seemed like a change in direction when first announced, but now looks like it is a very good strategic fit with the core graphene business. In conclusion, I’m glad I went along to the AGM. The risk / reward profile is looking increasingly attractive although I suspect the shares will fall further in the next few months. I will therefore look to top up as we approach the end of the tax year in April, but I'll probably keep my powder dry up until then. | timbo003 | |
04/12/2014 19:00 | I attended the AGM on Wednesday and will write up some notes tonight or tomorrow but need to do a bit of research into the IP beforehand. I do however feel quite a bit more relaxed about the company's strategy and prospects. | timbo003 | |
01/12/2014 15:51 | The AGM is at 2.00 this Wednesday in London. Having let all the information gleaned at the Proactive investor event sink in, my main concern is Perpetuus. Haydale's Strategy of filing just one single patent application (Inventor Ian Walters) back in 2009 and then developing the process further (without filing additional patents) worries me, given that Perpetuus (and more specifically Ian Walters) have been filing multiple patents in the meantime. These patent applications may concern (or at least overlap) some of the technical improvements implemented by Haydale for their process, yet Haydale have opted to maintain these improvements as trade secrets and "know how" without any disclosure that predates the new Perpetuus patent applications, or filing for any IP protection of their own. This begs the question: Will Haydale still have freedom to operate, or will their newly refined technological improvements be dominated any of these new Perpetuus patent applications? | timbo003 | |
21/11/2014 15:56 | The slide set from the Proactive investor meeting is here: ....and the Proactive page on Haydale is here (worth a browse): Ray Gibbs (CEO) gave the presentation, also present at the meeting was Matt Wood (CFO) and Gerry Boyce (former owner of recent acquisition EPL and now large Haydale shareholder). I asked about Perpetuus during Q&As and also spoke to Matt Wood about Perpetuus during post meeting drinks and Canapes. They were obviously aware of their Activities, but stated that they wouldn't know whether their activities were within the scope of Haydales patent applications until details of Perpetuus patent application published in May 2015 Haydale's process patent application spec can be found here: The Haydale IP and Perpetuus are dicussed in the admission document which can be found here (page 38): An opinion often expressed in IP circles is that it is often difficult to police process patents, especially when the processes may be being used in remote jursdictions with lax patent enforcement laws. I have since looked Perpetuus up at the IPO web site, they in fact have 5 patent applications, which are due to publish between May 2015 and November 2016 They will need to study these applications very thoroughly when they publish to answer two important questions: * Are Perpetuus operating outside the scope of the Haydale patents? (go after them if they are within the scope) * Do the Perpetuus patent applications in any way restrict Haydale's freedom to operate? I spoke to both Matt and Gerry at some length after the meeting and I must say I am now feeling quite a bit more relaxed about my investment in Haydale and might even add a few to my ISA over the coming weeks. I was relieved to hear that they do not anticipate any further fund raising and the strategy of extracting on going royalties from manufacturers means a recurring income stream. The EPL acquisition makes sense now and they still have £5M in the bank to execute the plan. The AGM is on Wednesday Dec 3rd (London), I plan to attend. | timbo003 | |
12/11/2014 10:53 | CEO Ray Gibbs is presenting on 20th November. To register please click here: | aim_trader | |
07/11/2014 17:46 | timbo003:- thanks for your links - The perpetuus site looks very professional and (imo) is stronger than HAYD's. Have fun at Proactive. Any feedback would be appreciated - While still on my watch list dropped back to possible from probable. PS> Not sure what is happening to the BB listings on the HAYD quote page - I was only able to access via the seach mechanic- Maybe just a temporay ADVFN glitch - I will check back later Edited:- BB Discussions now live again on Quote page so just a glitch - Nothing sinister. | pugugly | |
05/11/2014 08:56 | Thanks Aim Trader, I have now registered and will be going along to that event. They will be getting some questions (from me) about Perpetuus See post #7 on this thread Perpetuus are now very much up and running and they clearly have Haydale in their sights: So... * Do the statements in the pathfinder regarding perpetuus still apply? * How are Haydale going to respond to this threat? These are now worth more dead than alive to me, I certainly wouldn't want any more at the moment. I want to see some financial commitment from the directors with some decent buying at these levels, they are not in a closed period now (buying just 8000 shares doesn't count) and I would like some decent answers to the questions above before I would risk any more cash. | timbo003 | |
04/11/2014 13:21 | CEO Ray Gibbs is presenting at the Proactive Investor Forum on 20th November. To register click here: | aim_trader | |
03/11/2014 07:49 | Purchase of a consultancy/testing group. MM's have marked up but still not a break through in sales. Unless growth in revenue a potential 3 year time bomb. Still very much on the side. | pugugly | |
30/10/2014 15:51 | 58,470 unloaded at 59p Continues to fall with apparently very little buying support. Agreed with timb003 re EIS relief but remember there was a preplacing of £1.89 million of stock at 93p in a pre placing offering in September 2013 and no lock in agreement so these have a much lower base for EIS relief so quite possible the share price will continue to slide until significant revenue generated. Anyone know when or if contracts are likely to be announced ? | pugugly | |
12/10/2014 21:12 | Haydale are priced at close to cash in the bank now, so no reason to sell. Besides the shares are now worth a minimum of 67p/share to investors who bought in the IPO (even if they go bust), due to the generous EIS loss relief, so no point selling whatsoever. Summary of EIS tax reliefs (for the uninitiated or forgetful): I see that Haydale will be presenting at the Proactive investor meeting on November 20th (meeting commences 18.00) I assume the AGM will be around about then too, but no date has been announced yet. | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions